Taizhou Volsen Chemical Co., Ltd.
Casa> Blog> Pralsetinib

Pralsetinib

January 15, 2024
Pralsetinib cas number 2097132-94-8 ,also known as GAVRETO, is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. It is used to treat certain cancers caused by abnormal RET genes.iT is a targeted therapy that is taken by mouth once daily. 
Contattaci

Author:

Ms. Amy Cheng

Phone/WhatsApp:

008613566652212

Prodotti popolari
Notizie espositive
Blog News
What is the Tapinarof?

January 02, 2024

Tezacaftor and Ivacaftor

December 29, 2023

You may also like
Related Categories

Mail a questo fornitore

Oggetto:
E-mail:
messaggio:

Your message must be betwwen 20-8000 characters

Contattaci

Author:

Ms. Amy Cheng

Phone/WhatsApp:

008613566652212

Prodotti popolari
Notizie espositive
Blog News
What is the Tapinarof?

January 02, 2024

Tezacaftor and Ivacaftor

December 29, 2023

Casa

Product

Phone

Chi siamo

inchiesta

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Invia